Nadolol
规格
42200-33-9CAS 号
255-706-3EC 号
(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diolIUPAC 名称
C17H27NO4化学式
309.4 g/mol分子量
nadolol; Corgard; 42200-33-9; (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol; Solgol; SQ-11725; Anabet; (2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; DTXSID3023342; Corzide component nadolol; Nadololum; FEN504330V; NSC-758430; Nadolol [USP MONOGRAPH]; 1-(tert-Butylamino)-3-((5,6,7,8-tetrahydro-cis-6,7-dihydroxy-1-naphthyl)oxy)-2-propanol; 2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, cis-; cis-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxy-propoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol; Nadolol (USP MONOGRAPH); 2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-; 1-(tert-butylamino)-3-[(5,6,7,8-tetrahydro-cis-6,7-dihydroxy-1-naphthyl)oxy]-2-propanol; SQ11725; nadololo; 2,3-Naphthalenediol, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-; RefChem:55685; CHEBI:7444; C07AA12; DTXCID40209297; 255-706-3; 2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol; SQ 11725; Nadolol [MI]; Nadolol [HSDB]; Nadolol [INN]; Nadolol [JAN]; Nadolol [USAN]; Nadolol [VANDF]; Nadolol [MART.]; Nadolol [WHO-DD]; 1164498-31-0; Nadolol [ORANGE BOOK]; MLS000028580; MFCD00079476; 1403-22-1; SMR000058975; Corgard;Solgol; DTXCID903342; SR-01000000251; UNII-FEN504330V; Nadolol CRS; NCGC00016851-01; 220045-89-6; Prestwick_108; Nadolol [EP]; Nadolol [USP]; CAS-42200-33-9; Nadolol [USP-RS]; Spectrum_001643; Opera_ID_1099; Prestwick0_000818; Prestwick1_000818; Prestwick2_000818; Spectrum2_001546; Spectrum3_001586; Spectrum4_000193; Spectrum5_001255; CHEMBL649; SCHEMBL4177; Nadolol component of corzide; Nadolol, analytical standard; BSPBio_003152; GTPL554; KBioGR_000765; KBioSS_002123; cid_39147; MLS001148087; MLS002548875; DivK1c_000427; Nadolol (JP18/USP/INN); NADOLOL [EP IMPURITY]; SPECTRUM1503260; SPBio_001392; SPBio_002636; NADOLOL [EP MONOGRAPH]; INV102; orb1225078; Nadolol 1.0 mg/ml in Methanol; SCHEMBL29687486; BDBM25766; HMS501F09; KBio1_000427; KBio2_002123; KBio2_004691; KBio2_007259; KBio3_002652; INV-102; NINDS_000427; HMS1570D17; HMS1922O05; HMS2093A15; HMS2233E12; HMS3259C07; HMS3714D17; Pharmakon1600-01503260; MSK10064; Nadolol [USAN:INN:JAN:WHO-DD]; Tox21_110646; CCG-39324; EBC-26725; NSC758430; s5023; AKOS015895037; Tox21_110646_1; DB01203; FN26118; NC00464; IDI1_000427; SMP1_000203; NCGC00021623-03; NCGC00021623-05; NCGC00021623-06; NCGC00089811-02; (2R,3S)-5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; SBI-0051806.P002; NS00000501; EN300-50860; VU0239635-6; A12516; D00432; AB00052338_13; Q424952; SR-01000000251-2; SR-01000000251-3; BRD-A87606379-001-03-4; BRD-A87606379-001-13-3; BRD-A87606379-001-22-4; BRD-A87606379-001-23-2; Nadolol, European Pharmacopoeia (EP) Reference Standard; Z608060832; Nadolol, United States Pharmacopeia (USP) Reference Standard; (2R,3S)-5-[3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-2,3-diol同义词
